Financial Performance - The company has experienced recurring net losses since its inception in 2000, highlighting ongoing financial challenges [61]. - Net loss for 2024 was 41.670 million in 2023, reflecting a 45.9% increase in losses [234]. - Net loss per share for 2024 was 0.90 in 2023 [231]. - Comprehensive loss for 2024 was 41.399 million in 2023 [234]. - Total revenue for 2024 was 209.921 million in 2023 [231]. - Product revenue declined to 156.666 million in 2023 [231]. - Gross profit for 2024 was 46.113 million and 22.0% in 2023 [231]. - Operating expenses increased to 92.879 million in 2023 [231]. - Cash flows from operating activities resulted in a net cash used of 10.09 million in 2023 [239]. - The company reported a loss before income taxes of 42.65 million in 2023, indicating a worsening of approximately 42.6% [305]. Revenue and Sales - Industrial sales decreased to 71.0 million in 2023, a decline of 35.8% [273]. - Aerospace and Defense sales increased to 91.4 million in 2023 [273]. - The U.S. Government accounted for 19% of total revenues in 2024, up from 18% in 2023 [276]. - North America sales were 129.3 million in 2023 [273]. Assets and Liabilities - Total assets decreased to 306.8 million in 2023, reflecting a decline of about 11.9% [229]. - Total liabilities increased slightly to 52.4 million in 2023, representing a rise of approximately 2.7% [229]. - The accumulated deficit grew to 264.3 million in 2023, indicating an increase of about 23% [229]. - The company reported inventory of 52.2 million in 2023, indicating a reduction of approximately 21.2% [223]. - Contract assets increased by 99% to 7.3 million in 2023 [273]. - Contract liabilities increased by 7% to 6.4 million in 2023 [273]. Cash and Investments - As of December 31, 2024, cash and cash equivalents totaled 34.9 million [207]. - The company had a net cash provided by investing activities of 14.10 million in 2023 [239]. - Realized gains from marketable securities were 2.4 million in 2023 [279]. Research and Development - Research and development expenses were 46.163 million in 2023 [231]. - Research and development costs are expensed as incurred, reflecting the company's commitment to innovation and product development [257]. Employment and Workforce - Approximately 650 out of nearly 800 full-time employees are based in the United States, indicating a strong domestic workforce [51]. - Labor shortages and turnover can impact operational efficiency and increase labor costs, affecting overall business performance [83]. Market and Competition - The laser industry is facing declining average selling prices, necessitating increased volumes and cost reductions to maintain profitability [60]. - Competition in the industry is intense, with larger competitors having greater resources, which may pressure pricing and market share [42]. - The markets served are characterized by rapid technological change, requiring significant research and development expenditures [57]. Risks and Compliance - The company is subject to risks related to U.S. government contracts, including potential termination and changes in government spending, which could impact financial results [90]. - The company faces risks from international operations, including macroeconomic conditions, regulatory changes, and political instability, particularly in China [93]. - The company is exposed to foreign currency risk, which may adversely affect revenues and operating margins due to fluctuations in exchange rates [95]. - The company must comply with U.S. export controls, and failure to obtain necessary export licenses could harm international revenues [99]. - The company faces significant compliance costs related to privacy, data protection, and information security laws, which could adversely affect its financial condition [111]. Tax and Deferred Tax Assets - The company has estimated U.S. federal net operating loss carryforwards (NOLs) of 52.9 million as of December 31, 2024 [120]. - The company reported U.S. research and development credit carryforwards of 84.403 million, an increase from 710 thousand in 2024, compared to 9.0 million in 2024, highlighting ongoing uncertainty regarding the realizability of these assets [307]. Inventory and Fixed Costs - The company has high levels of fixed costs and inventory, which may adversely affect gross profits if product demand declines [65]. - The company recorded an adjustment to inventory values due to excess and obsolete inventory, which was assessed at 4.47 million in 2023 to 40.8 million as of December 31, 2024 [223]. - The company performed a quantitative test for goodwill impairment in 2024, concluding that the fair value of reporting units significantly exceeded their carrying values, indicating no impairment [247]. - The total restructuring charges for 2024 amounted to 0.82 million recorded in 2023 [303].
nLIGHT(LASR) - 2024 Q4 - Annual Report